Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.
about
Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsCord Blood as a Source of Natural Killer CellsUmbilical cord blood transplantation for the treatment of hematologic malignanciesImproving the outcome of leukemia by natural killer cell-based immunotherapeutic strategiesBiology and clinical effects of natural killer cells in allogeneic transplantation.Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantationNCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell TrNatural killer cell mediated missing-self recognition can protect mice from primary chronic myeloid leukemia in vivo.Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia.Umbilical cord blood transplantation: the first 25 years and beyond.Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord bloodHow I treat: the selection and acquisition of unrelated cord blood grafts.Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.Immune Reactions following Cord Blood Transplantations in Adults.T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.Genetics of graft-versus-host disease: the major histocompatibility complex.Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donorsHaploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.Killer Cell Immunoglobulin-Like Receptor-Ligand Matching and Outcomes after Unrelated Cord Blood Transplantation in Acute Myeloid LeukemiaReexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission.Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responsesThe biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).Mouse models in bone marrow transplantation and adoptive cellular therapy.Role of natural killer cells in hematopoietic stem cell transplantation: myth or reality?An overview of the progress on double umbilical cord blood transplantation.Use of NK cell activity in cure by transplant.Umbilical cord blood immunology: relevance to stem cell transplantation.Clinical relevance of natural killer cells following hematopoietic stem cell transplantation.At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies.The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation.Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de GrUmbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Impact of HLA in cord blood transplantation outcomes.Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.
P2860
Q26751011-38ACD0E1-81D4-4DAC-A30E-4C1F3CEE24DDQ26771337-63886CA7-A435-4B56-A8D0-98A1E19941EBQ26820829-B7EF8920-8305-4512-83CD-D24FA9EE09B1Q26996660-245EC052-0271-41E8-A44A-ECD49A6F6310Q33893173-687A5A42-BA50-45CB-9189-8AF935F39A8BQ34033553-99AA2792-52D3-4A87-A81D-462659AF36B8Q34044024-EE26BFDE-093D-49BE-9D1E-B658AD0D4092Q34087767-788786E5-90E2-44E3-AE96-AA0ECA596AC3Q34232835-6489A6D5-BFF9-4DBE-A825-BF21A654EF80Q34344669-FCE4D195-EBDF-46EC-A871-778A6B8D7E9FQ34374133-9CF282E3-56C4-418F-841E-D790713CB448Q34707580-EF448338-50AE-487C-B9FC-26C28B02BDD6Q35034803-F9EE83EB-0F74-46C4-ADEA-5933D0215A6AQ35054475-7D0E1CE2-E28F-4319-B82C-2D811BA66EF7Q35871747-BE28BA69-88C3-426F-B37B-3E72FF99C7FEQ35958215-E291EA3B-87E2-4323-88BA-E988D6296D63Q36366949-C6874341-5D5E-4D80-BC0B-850E60E2167AQ36766250-584CF016-87BF-4E41-9B0C-79CF28D3795CQ36775731-2E845A9D-5C82-4A04-89CD-FB89405408E4Q36999109-3CCB6B3E-77F6-4779-AFDB-D1A523394EFDQ37024340-A69016CC-8931-4ACC-AD32-908BD113D706Q37415942-E9C00629-AF7F-423B-8B9D-5997B77C395EQ37432020-2BFF4690-DD90-4D7C-988E-E981179D8614Q37524719-D98CBCA9-ACC9-4FD0-A6D5-B62769F07A71Q37589671-34D9A0D4-EC21-49FB-B2A8-9A29BE7A6B99Q37677563-0AB87890-EE7D-4184-BC20-27074A3B43D3Q37853787-FDEED7B7-CDF4-4C0E-BA37-2CD4F49D6FB4Q37872506-B1C2ABAA-E1FF-42E2-9427-8E852E7010FCQ37910960-3C0475DF-F457-40F1-A92B-77D236F75F3CQ37963798-31347091-F52E-49EC-9B03-5C9A7BF723CFQ38079585-18763DA5-C70B-4BDB-8368-1776015E6385Q38149725-8AC0EBA1-AEE1-4628-A588-BF6E52FD69C5Q38513534-E77CA17C-3E96-4ED5-9C96-11A395587B96Q38586429-D3C6825B-330D-47E7-838F-FDD94F178272Q38656322-3779975E-A434-42FE-B1AD-80A8648983B7Q38666661-25FB8A00-B254-4CD0-981C-2BFA091A59E9Q38733830-5B764CE8-0AA6-4545-8677-24385CCB9468Q38747929-094DF47A-F0A7-46A3-9330-07244A3DB9B9Q38802750-7116E715-FF38-4A51-8CCB-E295A9C8C965Q39117286-6276CFE3-7C65-41A7-901C-A8947F5EBBA9
P2860
Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Negative effect of KIR allorea ...... tation conditioning intensity.
@en
Negative effect of KIR allorea ...... tation conditioning intensity.
@nl
type
label
Negative effect of KIR allorea ...... tation conditioning intensity.
@en
Negative effect of KIR allorea ...... tation conditioning intensity.
@nl
prefLabel
Negative effect of KIR allorea ...... tation conditioning intensity.
@en
Negative effect of KIR allorea ...... tation conditioning intensity.
@nl
P2093
P2860
P1433
P1476
Negative effect of KIR allorea ...... tation conditioning intensity.
@en
P2093
Claudio G Brunstein
Daniel J Weisdorf
Harriet Noreen
Jeffrey S Miller
John E Wagner
Juliet N Barker
Michael R Verneris
Sarah Cooley
Todd DeFor
P2860
P304
P356
10.1182/BLOOD-2008-12-197467
P407
P577
2009-03-27T00:00:00Z